ES2161682T3 - Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion. - Google Patents

Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion.

Info

Publication number
ES2161682T3
ES2161682T3 ES91118349T ES91118349T ES2161682T3 ES 2161682 T3 ES2161682 T3 ES 2161682T3 ES 91118349 T ES91118349 T ES 91118349T ES 91118349 T ES91118349 T ES 91118349T ES 2161682 T3 ES2161682 T3 ES 2161682T3
Authority
ES
Spain
Prior art keywords
hcv
suitable agents
specific peptides
procedure
invention concerns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91118349T
Other languages
English (en)
Inventor
Udo Dr Krupka
Werner Dr Stuber
Manfred Dr Gerken
Stefan Dr Brust
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27435056&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2161682(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4034982A external-priority patent/DE4034982C2/de
Priority claimed from DE4112743A external-priority patent/DE4112743C2/de
Priority claimed from DE4120281A external-priority patent/DE4120281C2/de
Priority claimed from DE4121431A external-priority patent/DE4121431A1/de
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2161682T3 publication Critical patent/ES2161682T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA INVENCION CONCIERNE A POLIPEPTIDOS PARA LA DETERMINACION INMUNOQUIMICA DE ANTICUERPOS ESPECIFICOS-HCV Y DE ANTIGENOS-HCV, ASI COMO A LOS MEDIOS APROPIADOS PARA EL PROCEDIMIENTO Y SU APLICACION. LA INVENCION CONCIERNE TAMBIEN A UN PROCEDIMIENTO INMUNOQUIMICO PARA LA VERIFICACION SIMULTANEA Y/O PARA LA DETERMINACION SIMULTANEA, EN UN TEST UNICO, DE OTRAS ESPECIFICIDADES DISTINTAS DE LOS ANTICUERPOS CONTRA DIFERENTES PATOGENOS.
ES91118349T 1990-11-03 1991-10-28 Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion. Expired - Lifetime ES2161682T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4034982A DE4034982C2 (de) 1990-11-03 1990-11-03 Synthetische Polypeptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
DE4112743A DE4112743C2 (de) 1991-04-19 1991-04-19 Synthetische Core-Peptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
DE4120281A DE4120281C2 (de) 1991-06-19 1991-06-19 Immunchemisches Verfahren zum gleichzeitigen Nachweis von mehreren verschiedenen Antikörperspezifitäten, Peptidmischungen und Test dazu
DE4121431A DE4121431A1 (de) 1991-06-28 1991-06-28 Synthetische core-peptide zur bestimmung von hcv-antikoerpern und hcv-antigenen, mittel dazu und ihre verwendung in diesen nachweis-verfahren

Publications (1)

Publication Number Publication Date
ES2161682T3 true ES2161682T3 (es) 2001-12-16

Family

ID=27435056

Family Applications (2)

Application Number Title Priority Date Filing Date
ES91118349T Expired - Lifetime ES2161682T3 (es) 1990-11-03 1991-10-28 Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion.
ES96112414T Expired - Lifetime ES2255068T5 (es) 1990-11-03 1991-10-28 Peptidos especificos para vhc, sus agentes y su utilizacion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES96112414T Expired - Lifetime ES2255068T5 (es) 1990-11-03 1991-10-28 Peptidos especificos para vhc, sus agentes y su utilizacion.

Country Status (8)

Country Link
EP (2) EP0770679B2 (es)
JP (2) JP4097162B2 (es)
AT (2) ATE318309T1 (es)
AU (1) AU657497B2 (es)
CA (1) CA2054798C (es)
DE (2) DE59109221D1 (es)
DK (2) DK0484787T3 (es)
ES (2) ES2161682T3 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6312889B1 (en) 1990-04-04 2001-11-06 Chiron Corporation Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6007982A (en) * 1990-12-14 1999-12-28 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
US5910404A (en) * 1990-12-14 1999-06-08 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
ATE185350T1 (de) * 1990-12-14 1999-10-15 Innogenetics Nv Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
DK0569537T3 (da) * 1991-01-31 1999-04-06 Abbott Lab Monoklonale antistoffer mod formodede HCV-kapperegioner og fremgangsmåder til anvendelse deraf
GB9105871D0 (en) * 1991-03-20 1991-05-08 Inst Cientifico Tecnol Navarra Synthetic peptides
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
AU648912B2 (en) * 1991-06-13 1994-05-05 Dade International Inc. Immunoassay for non-A non-B hepatitis
HU227547B1 (en) * 1991-06-24 2011-08-29 Novartis Vaccines & Diagnostic Hepatitis c virus (hcv) polypeptides
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
EP0525910A1 (en) * 1991-08-02 1993-02-03 Akzo Nobel N.V. Non-A, non-B peptide
ATE228564T1 (de) * 1991-09-13 2002-12-15 Chiron Corp Zusammensetzung aus mehreren immunreaktiven hepatitis-c-virus-polypeptiden
DE610436T1 (de) * 1991-11-21 1995-08-03 Common Services Agency Detektion des Hepatis-C Virus.
WO1993011158A2 (en) * 1991-12-06 1993-06-10 Akzo Nobel N.V. Non-a, non-b peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
ES2287969T3 (es) * 1992-03-06 2007-12-16 Innogenetics N.V. Peptidos de vih.
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
FR2690921B1 (fr) * 1992-05-06 1995-06-30 Bio Merieux Polypeptides de synthese appartenant au virus de l'hepatite c (vhc) et utilisables notamment pour detecter ce dernier.
DE69334323D1 (de) * 1992-07-16 2010-05-06 Advanced Life Science Inst Inc Antigenetische Peptide für die Gruppierung des Hepatitis C Virus sowie Reagenzien und Verfahren dafür
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
GB2282884A (en) * 1993-04-14 1995-04-19 Int Murex Tech Corp Immunoassay
FI945857L (fi) * 1993-04-14 1994-12-13 Int Murex Tech Corp Immunomääritys
JPH07135981A (ja) * 1993-05-28 1995-05-30 Eisai Co Ltd 非ａ非ｂ型肝炎ウイルス遺伝子に由来するｄｎａ及び構成ポリペプチド
CA2125467C (en) * 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
US5670310A (en) * 1994-07-29 1997-09-23 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection
JP3665371B2 (ja) * 1994-08-31 2005-06-29 株式会社先端生命科学研究所 Ｃ型肝炎ウイルス感染又はグループ判定のためのエピトープキメラ抗原ペプチド、その製法、及びそれを使用する感染又はグループ判定法
DE19540105C1 (de) * 1995-09-19 1997-02-20 United Biomedical Inc Peptidzusammensetzungen zur Diagnose und zum Nachweis von Hepatitis C Virus (HCV)-Infektion
DE19637718A1 (de) 1996-04-01 1997-10-02 Boehringer Mannheim Gmbh Rekombinante inaktive Core-Streptavidin Mutanten
GB9624750D0 (en) * 1996-11-28 1997-01-15 Univ London Capture assays
FR2760367B1 (fr) 1997-03-06 1999-04-30 Pasteur Merieux Serums Vacc Composition vaccinale destinee a la prevention ou au traitement des hepatites c
AU3714499A (en) * 1998-05-14 1999-11-29 Pasteur Merieux Serums Et Vaccins Hepatitis c virus mimotopes
ATE303597T1 (de) * 2000-07-07 2005-09-15 Medmira Inc Hcv mosaik antigen zusammensetzung
FR2987836A1 (fr) * 2012-03-09 2013-09-13 Biomerieux Sa Peptides d'interference et procede de detection de microorganismes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318216B2 (en) * 1987-11-18 2001-08-29 Chiron Corporation NANBV diagnostics
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
JP3156200B2 (ja) * 1989-09-15 2001-04-16 国立予防衛生研究所長 新規のｈｃｖ分離株
CA2032907C (en) * 1989-12-22 2002-05-14 Richard R. Lesniewski Hepatitis c assay
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
AU635124B2 (en) * 1990-04-16 1993-03-11 United Biomedical Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
ATE185350T1 (de) * 1990-12-14 1999-10-15 Innogenetics Nv Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus

Also Published As

Publication number Publication date
JP2003192697A (ja) 2003-07-09
JP4097162B2 (ja) 2008-06-11
ES2255068T3 (es) 2006-06-16
DK0770679T4 (da) 2010-05-10
CA2054798C (en) 2009-08-18
EP0770679A2 (de) 1997-05-02
DE59109271D1 (de) 2006-04-27
EP0770679A3 (de) 1997-05-21
DE59109221D1 (de) 2001-11-15
AU657497B2 (en) 1995-03-16
DK0770679T3 (da) 2006-04-03
EP0484787B1 (de) 2001-10-10
JPH04330098A (ja) 1992-11-18
AU8700291A (en) 1992-05-07
EP0484787A2 (de) 1992-05-13
EP0484787A3 (en) 1992-08-12
ES2255068T5 (es) 2010-08-03
EP0770679B1 (de) 2006-02-22
CA2054798A1 (en) 1992-05-04
EP0770679B2 (de) 2009-12-30
ATE318309T1 (de) 2006-03-15
ATE206717T1 (de) 2001-10-15
DK0484787T3 (da) 2002-02-04
JP4097191B2 (ja) 2008-06-11

Similar Documents

Publication Publication Date Title
ES2161682T3 (es) Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion.
GB2002090B (en) Gas valve seating member
ES2173284T3 (es) Agentes endoparasicitidas.
ATE155818T1 (de) Nicht glycosylierter anti-cd3-igg-antikörper
DE59003860D1 (de) Beleuchtungsvorrichtung für Projektionszwecke.
FI953843L (fi) Ultraäänivarjoaineina käyttökelpoisia kaasuseoksia
IT7824232A0 (it) Valvola franante lo scarico di gas.
DE68923401D1 (de) Peptide mit T-Zellen-Helfer-Wirksamkeit.
DE69009240D1 (de) Ventilanordnung mit Absperrventil für Gasbehälter.
MX150154A (es) Mejoras en valvula excentrica de tipo esferico y en el procedimiento para su fabricacion
NO921256D0 (no) Aminosyre-beta-lyaseenzyminhibitor som deodoranter
ES2103854T3 (es) Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.
DE68919101D1 (de) Gasabschaltungsvorrichtung.
ES521273A0 (es) Procedimiento para el recubrimiento de cuero desdoblado.
ES2168253T3 (es) Peptidos especificos para hcmv y su utilizacion.
AR225643A1 (es) Asiento de valvula
NL186029B (nl) Klepinrichting in een toevoerkanaal voor behandelde lucht.
BR9001238A (pt) Valvula de saida para compressor
DK0459376T3 (da) Kombineret afspærringsventil
DE69001352D1 (de) Dichtendes absperrventil.
FI912825A7 (fi) Avspaerrningsventil.
AT379879B (de) Gasabsperrhahn
NL192889B (nl) Gasflesafsluiter.
NO791933L (no) Ventilsete.
ATA274689A (de) Gasabsperrhahn

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 484787

Country of ref document: ES